Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 6, 2006, Pages 1167-1172

  Hogg, Ronald J ^a   Fitzgibbons, Lisa ^a   Atkins, Carolyn ^a   Nardelli, Nancy ^a   Bay, R Curtis ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ENALAPRIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; PLACEBO;

ADULT; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG COMBINATION; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; MICROCAPSULE; MULTICENTER STUDY; PATIENT SELECTION;

ADULT; CAPSULES; CHILD; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; ENALAPRIL; FATTY ACIDS, OMEGA-3; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; PATIENT SELECTION; PHOSPHOLIPIDS; PLACEBOS;

EID: 34548547307     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02300606     Document Type: Article

References (0)